2018 Pan Pacific Lymphoma Conference
Course Info   Agenda   Abstracts   Travel   Supporters   Register

2018 Pan Pacific Lymphoma Conference

July 16-20, 2018
Hyatt Regency Maui Resort & Spa, Hawaii

Register to Attend

More than 20 Years of Educational Excellence

The Pan Pacific Lymphoma Conference is one of the largest gatherings of clinicians and researchers specializing in the area of lymphoma and transplantation. The 2018 event is your chance to explore vital information on clinical updates and research, meet key thought leaders, and exchange ideas with more than 500 members of the multidisciplinary lymphoma clinical team including oncologists, hematologists, pathologists, clinical scientists, nurse practitioners, physician assistants, nurses, and pharmacists.


Conference Objectives

At the conclusion of the conference, the participant should be better able to:

  1. Evaluate results of clinical trials with current and emerging agents and regimens to develop evidence-based clinical management strategies in patients with Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL)
  2. Formulate evidence-based management strategies for the optimal management of patients with lymphoma, leukemia and myeloma, inclusive of multi-modality therapies and maintenance-based regimens
  3. Analyze underlying molecular and cytogenetic abnormalities contributing to hematologic malignancies and their impact on diagnosis, prognosis, and therapeutic approaches
  4. Evaluate the optimal patient selection, timing, and regimen for stem cell transplant and chimeric antigen receptor (CAR-T) cell therapy for patients with lymphoma
  5. Personalize the treatment of hematologic malignancies based upon patient and disease-specific characteristics, and manage treatment-related adverse effect appropriately
  6. Provide accurate and appropriate counsel as part of the treatment plan
  7. Review factors that impact patient selection, availability and enrollment into clinical trials examining novel agents under investigation in patients with lymphoma, leukemia and myeloma

Conference Directors

James Armitage, MD James O. Armitage, MD
Joe Shapiro Professor of Medicine
Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
Matthew Lanning, DO Matthew A. Lunning, DO
Assistant Professor
Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
Julie Vose MD Julie M. Vose, MD, MBA
Neumann M. and Mildred E. Harris Professor
Chief, Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
   

Continuing Education Credit

This live activity has been approved for AMA PRA Category 1 Credits™.


Sponsors

This conference is sponsored by the UNMC Department of Internal Medicine – Division of Oncology and Hematology, the UNMC College of Nursing Continuing Nursing Education, with the UNMC Center for Continuing Education.


For More Information

Contact Brenda Ram, CMP, CHCP via email or call 402-559-9250.